--Canadian private equity fund Brookfield Asset Management has resumed talks with Spanish pharmaceutical company Grifols over a potential takeover bid, five months after dropping out of a first set of negotiations to acquire Grifols, Spain's news website El Confidencial reports, citing unnamed sources.
--The new bid would be for a 7 billion purchase price, El Confidencial writes, citing the same sources.
--Brookfield's general director, Tristan Tully, is holding the talks with the Grifols family through Morgan Stanley, and has requested more detailed information about the producer of plasma-derived medicines, the article says.
--Grifols declined to comment to El Confidencial.
Full story in Spanish: https://tinyurl.com/3f48nxny
Write to Cristina Gallardo at cristina.gallardo@wsj.com
(END) Dow Jones Newswires
April 02, 2025 04:44 ET (08:44 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。